Home/Pipeline/Sildenafil-loaded Z-pods®

Sildenafil-loaded Z-pods®

Erectile dysfunction

Pre-clinicalActive

Key Facts

Indication

Erectile dysfunction

Phase

Pre-clinical

Status

Active

Company

Atticus Pharma

About Atticus Pharma

Atticus Pharma is a private, pre-revenue biotech leveraging its proprietary Z-pods® silica particle technology for sustained, localized drug delivery. Its lead programs target immunodermatology (cutaneous lupus) and androgenic alopecia, with a third exploring topical sildenafil for erectile dysfunction. The company's strategy aims to improve therapeutic efficacy and safety by creating localized drug depots, thereby minimizing systemic exposure and side effects associated with current oral or topical treatments.

View full company profile

Therapeutic Areas

Dermatology Inflammatory Diseases Oncology

Other Erectile dysfunction Drugs

Drug	Company	Phase	Status
CF602	Can Fite Biopharma	Preclinical	Active
E300 ESWT System	Wikkon	Commercial	Market Released
Sildenafil Citrate	Azico Biophore	Commercial	Active
Sildenafil Formulation	InnovaZone Labs	Approved	Active
Rigi10™ Malleable Penile Prosthesis	Rigicon	Approved	Commercial
UNITED Study (Investigational Inflatable Penile Prosthesis)	Rigicon	Clinical Investigation	Active
ASP-001	Aspargo Laboratories	Approved	Active
FGF-based Therapeutic	Venturis Therapeutics	Pre-clinical	Active
TPN171 (Simenafil hydrochloride) Tablets	Vigonvita	Approved	Marketed in China and Uzbekistan
DehydraTECH-sildenafil	Lexaria Bioscience	Human Clinical	Active